Genetic signaling pathway blocks formation of a cancer in the cerebellum
A research team at the Krembil Research Institute has discovered that a signaling pathway which controls blood vessel development in the brain has the ability to stop brain tumor formation in animal models of medulloblastoma, the most common malignant brain tumor diagnosed in children.
The findings, published in the journal eLife, are the first to show that blocking a signaling pathway called Norrin/Frizzled4 (Fzd4) drives changes in the support structures that surround pre-cancer cells and promotes medulloblastoma development in subjects that are genetically susceptible to the disease.
"Our study brings a new dimension to our understanding of Medulloblastoma," says Dr. Valerie Wallace, principal investigator of the study, Norrin/Frizzled4 Signaling in the Preneoplastic Niche Blocks Medulloblastoma Initiation, and Co-Director of the Donald K. Johnson Eye Institute.
"It adds another component to understanding tumour initiation, which is a longstanding question in the field."
Her team's new research found that blocking the Norrin/Fzd4 signal created more opportunities to form pre-cancerous growths and speed up tumour initiation. This work also suggests that an activated pathway may therefore block tumour formation.
The research, which was carried out in large part by Dr. Erin Bassett and Mr. Nicholas Tokarew, was initiated at the Ottawa Hospital Research Institute and continued at the Krembil Research Institute after Dr. Wallace relocated to Toronto. The discovery came from replication of a human condition called Gorlin Syndrome in lab experiments. People with Gorlin Syndrome have one copy of a tumour-suppressing gene instead of two, which makes them susceptible to medulloblastoma.
"While there is some treatment success for medulloblastoma, it is not perfect," says Dr. Wallace. "Our research reveals new observations that down the road might change what happens in the clinic."
The team's next step will be to investigate how the blood vessels impacted by Norrin/Fzd4 signaling communicate with pre-cancerous cells to make them more likely to become malignant.
"We don't think that is due to a passive supply of nutrients from the vessels," Dr. Wallace explains. "The vessels play a role in the development of this cancer and we want to understand what that role is."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Bassett EA et al. Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. eLife, Published November 8 2016. doi: 10.7554/eLife.16764
We make judgements quite rationally or "by the gut". Not only experience and relevant information play an important role, but also our preferences. A study by the Max Planck Institute for Metabolism Research in Cologne shows how the reward system in the brain conveys judgements affected by one's own desires, and how our inner beliefs are altered more by good than bad news.
The emerging technology of sonogenetics—a technique where cells are controlled by sound—offers the potential to one day replace pharmaceutical drugs or invasive surgical treatments for neurological conditions like epilepsy, Parkinson’s disease or post-traumatic stress disorder. A new research program could take this technique to the next level with $750,000 of funding.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019